Hidden metastases reveal clues to colorectal cancer recurrence

Дата публикации: 09-07-2026 19:00:05

Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict recurrence after treatment. The findings suggest these tiny, often undetectable tumor deposits could serve as a tissue-based marker of residual cancer cells, recurrence risk and chemotherapy resistance.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery	0	7	03-07-2026
2	Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery	0	5	06-07-2026
3	Fatty liver drives a more dangerous form of colorectal cancer spread, study reveals	5	8	01-07-2026
4	What’s hiding inside colon cancer could change treatment	0	9.72	02-04-2026
5	Intratumoral Fusobacterium as a prognostic and predictive biomarker in resectable colorectal cancer	0	4.79	04-08-2026
6	New tool accurately predicts liver cancer recurrence	0	8.22	03-08-2026
7	No Difference in DFS Between Post-adjuvant Chemotherapy and Placebo In High-Risk Patients Identified Through ctDNA-based MRD Assessment After CRC Resection	0	5	22-06-2026
8	Hidden virus in your gut may be linked to colon cancer	0	6.48	22-04-2026
9	EMA Recommends Extension of Therapeutic Indications for Encorafenib	0	5	03-07-2026
10	Metabolic improvements cut MASLD-linked colorectal neoplasia risk	0	12.12	12-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 3. Информативность: 7. Источник: medicalxpress.com.